Target intelligence / Profile preview

NAV3 antisense RNA 1 (NAV3-AS1)

Target
NAV3-AS1
Molecular classification
Long noncoding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

NAV3 antisense RNA 1 (NAV3-AS1) is a long noncoding RNA transcribed from the opposite strand of the NAV3 gene locus. It is classified as a natural antisense transcript (NAT), a type of RNA species that can overlap with protein-coding genes and modulate their expression, primarily through transcriptional interference or epigenetic mechanisms[2]. Like other antisense RNAs, NAV3-AS1 may regulate the expression of its sense counterpart (NAV3) or other nearby genes, although its specific biological or pathophysiological roles have not been detailed in the literature to date. There is no evidence supporting NAV3-AS1 as a direct therapeutic target, and no drugs or established biomarkers involve this molecule at present[2]. Key distinction: - NAV3-AS1 is a regulatory noncoding RNA with potential roles in gene regulation but has not been characterized as a receptor, enzyme, or typical druggable therapeutic target. - If the intended focus was the protein-coding gene, use Neuron navigator 3 (NAV3) which encodes a microtubule-associated protein implicated in neurodevelopment and cancer and may have clearer roles in disease and therapeutic targeting[1][3][5][6].

Other names
NAV3-AS1NAV3 antisense RNA 1NAV3 lncRNA antisense 1
02

Biological functions

Regulation of gene expression (especially at the transcriptional level via transcriptional interference mechanisms)
03

Disease associations

Other

Beyond the preview

Go deeper on NAV3 antisense RNA 1 (NAV3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAV3 antisense RNA 1 (NAV3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call